DADATA·ANALYSIS
FREE
company · cik 1434868

Esperion Therapeutics, Inc.

ESPRNasdaqSIC 2834public
financials · annual · usd2026
Revenue$403.1M
Net income-$22.7M
Total assets$465.9M
Total liabilities$767.9M
Equity-$302.0M
LT debt$1.0M
Operating cash-$13.1M
money-flow · companies

No customer / supplier links anchored.

commodity exposure

No commodity exposure anchored.

places · hq + contracts1